Zepbound for Weight Loss
Eli Lilly's weight loss shot. Patients in the largest clinical trial lost an average of 22.5% of their body weight, the most of any FDA-approved weight loss drug.
Reviewed by GlobalGLP1 editorial team • Last reviewed March 2026 • Sources: FDA prescribing information, peer-reviewed clinical trials
Overview
Zepbound is a weekly injection from Eli Lilly that helps you lose weight by reducing appetite and slowing how fast your stomach empties. The FDA approved it in November 2023 for adults whose weight is affecting their health. It uses the same active ingredient as Mounjaro (which is approved for type 2 diabetes), but Zepbound is the version specifically labeled for weight loss. In the main study (called SURMOUNT-1), people on the highest dose lost about 22.5% of their starting body weight over about 17 months. For a 200-pound person, that's roughly 45 pounds.
How Zepbound Works
Zepbound works by activating two hunger-related hormones at once: GIP and GLP-1. Most older weight loss medications only target one. By hitting both, Zepbound reduces appetite more effectively, slows digestion, and changes how your body stores fat. You take it as a once-weekly shot (usually in the belly, thigh, or upper arm). This dual approach is why Zepbound produced the strongest weight loss results of any FDA-approved medication in clinical trials.
FDA Approval
Zepbound
Chronic weight management
2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg weekly injection
How You Take It
Each dose step lasts at least 4 weeks. The slow build-up reduces stomach side effects. Some people get great results at 5 mg or 10 mg without needing the highest dose. Your doctor will help you find the right level.
How Much Weight You Can Lose
In the main weight loss trial, people on the highest dose (15 mg) lost an average of 22.5% of their body weight over about 17 months. That is more than any other FDA-approved weight loss medication. About half of participants on 15 mg lost at least 20% of their body weight. For a 200-pound person, 22.5% is roughly 45 pounds. Lower doses also work: 5 mg averaged about 15% and 10 mg averaged about 19.5%. Results vary a lot from person to person.
Side Effects
Common Side Effects
- Nausea (about 29% of users at the 15 mg dose in SURMOUNT-1; usually worst during dose increases and eases over time)
- Diarrhea (about 23% of users; typically mild and short-lived)
- Decreased appetite (common; this is part of how the drug works)
- Vomiting (about 13% of users; tends to drop off after the first month or two)
- Constipation (about 12% of users)
- Abdominal pain (about 10% of users; usually mild)
- Indigestion / upset stomach (about 9% of users)
- Injection site reactions (uncommon; mild redness near the shot)
Rare but Serious
- Pancreatitis (rare)
- Gallbladder disease
- Thyroid C-cell tumors (boxed warning, rodent studies)
- Hypoglycemia (with insulin or sulfonylureas)
- Severe GI events
- Allergic reactions including anaphylaxis
Managing side effects: Similar pattern to semaglutide: stomach-related side effects show up most during the first few weeks and around dose increases, then ease as your body adjusts. The slow dose build-up exists for this reason. Eating smaller, more frequent meals and avoiding high-fat foods help. If vomiting is persistent or severe, contact your provider. They can slow or pause the dose escalation.
Zepbound Cost & Savings (2026)
Savings programs: Zepbound Savings Card: commercially insured patients can pay as little as $25/month. LillyDirect Self Pay: cash-paying patients can buy single-dose vials direct from Lilly for $349 to $699/month depending on dose.
Who Should Not Take Zepbound
- Personal or family history of a type of thyroid cancer called medullary thyroid carcinoma (MTC)
- A rare condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Allergy to tirzepatide or any ingredient in the medication
- Pregnancy or planning to become pregnant (stop at least 1 month before conception)
- Severe stomach or intestinal disease
What to Expect, Month by Month
Noticeable decrease in hunger and food noise. Some patients report reduced cravings for high-calorie foods specifically.
Consistent weight loss begins during dose escalation. Average 3-5% body weight lost. Dual GIP/GLP-1 action accelerates early results.
Approaching maintenance dose (10-15 mg). Steady 1-2.5 lbs per week loss. Blood sugar improvements prominent.
Average 15-20% body weight lost. Dramatic improvements in metabolic health markers, blood pressure, and lipids.
Weight loss plateau at 20-22.5% average. Some patients achieve 25%+ loss. Maintenance phase with sustained metabolic benefits.
Other Medications to Watch
Can cause dangerously low blood sugar when combined. Your doctor will likely reduce your insulin dose by 20 to 50% when starting tirzepatide, and may also lower your sulfonylurea dose.
Because tirzepatide slows digestion, pills you take by mouth may absorb differently. This is most noticeable during the first few months when dose changes are happening and stomach effects are strongest.
Slower digestion can change how warfarin absorbs. Your doctor should check your clotting levels (INR) more often when starting or changing your tirzepatide dose.
Birth control pills may absorb less effectively during the first weeks of treatment. Consider backup contraception (condoms) during the first 4 weeks and for 4 weeks after each dose increase, or switch to a non-oral method (patch, ring, IUD).
Special Situations
Do not use during pregnancy. Stop tirzepatide at least 1 month before trying to conceive. Animal studies showed harm to the fetus at high doses.
No dose change needed for mild or moderate kidney issues. Limited data in severe kidney disease. Watch for dehydration from nausea and vomiting, which can worsen kidney function.
No dose change needed for mild or moderate liver issues. Not studied in severe liver disease.
No dose change needed. Clinical trials included people aged 65 to 75. Slower dose increases may help reduce stomach side effects in older adults.
Not yet FDA-approved for adolescents. Clinical trials in teens (SURMOUNT-TEENS) are in progress. Some doctors prescribe it off-label for teens with severe obesity.
What Happens If You Stop
In the SURMOUNT-4 trial, people who stopped tirzepatide after 36 weeks regained about two-thirds of the weight they had lost over the following year. People who stayed on it continued to lose weight. This is why most doctors recommend staying on treatment long-term if it is working.
How to make stopping easier: Building healthy eating habits and regular exercise while on the medication is the best insurance against regain. Some doctors are exploring lower maintenance doses to keep weight off at lower cost. Start planning your long-term approach before stopping.
Zepbound FAQs
Zepbound and Mounjaro are the same drug (tirzepatide) at the same doses, just sold under different names for different uses. Mounjaro is the version approved for type 2 diabetes. Zepbound is the version approved for weight loss. Your doctor will prescribe whichever one matches your situation, and your insurance is likely to cover only the one that fits your diagnosis.
About $1,086 per month at most retail pharmacies. But Eli Lilly sells single-dose vials directly to cash-paying patients through a program called LillyDirect Self Pay: $349/month for the 2.5 mg or 5 mg dose, $499/month for 7.5 mg, and $699/month for 10 mg. That's often the cheapest legit way to pay cash.
It depends on the dose. In the main clinical trial, people on the 5 mg dose lost about 15% of their starting body weight on average. The 10 mg dose averaged about 19.5%, and the highest 15 mg dose averaged 22.5% over roughly 17 months. About half of patients on the 15 mg dose lost at least 20% of their body weight. Results vary a lot from person to person depending on diet, exercise, and how your body responds.
It depends on your plan. Many large commercial insurance plans now cover Zepbound, but they usually require prior authorization. That means your doctor has to send paperwork showing you qualify (typically a BMI of 30 or higher, or 27+ with another weight-related health condition). Medicare doesn't cover GLP-1s for weight loss alone, though a new temporary Medicare program starting in July 2026 may change that for some people. Use the clinic directory below to find providers that accept your insurance.
You need a prescription from a licensed doctor or nurse practitioner. You can get one in person or through a telehealth clinic, and many telehealth providers offer same-week video appointments. Use the directory below to compare clinics in your state that prescribe Zepbound, including their prices, telehealth options, and insurance accepted.
The most common side effects are stomach-related: nausea, diarrhea, vomiting, constipation, and stomach pain. They usually show up when you first start or move up to a higher dose, and most people find they get better after a few weeks. Rare but more serious risks include inflammation of the pancreas, gallbladder problems, and a warning about thyroid tumors (seen in animal studies, not confirmed in humans). Always tell your doctor about your full medical history before starting.
Yes, and it's common. Head-to-head studies show Zepbound (tirzepatide) tends to produce more weight loss than Wegovy or Ozempic (semaglutide) on average. Your doctor will usually start you on the lowest Zepbound dose (2.5 mg) when you switch, even if you were on a high dose before, so your body can adjust and you don't get hit with stomach side effects. Don't switch on your own. Talk to your prescriber first.
Find Clinics Offering Zepbound
Compare Zepbound providers by pricing, telehealth availability, and patient ratings.
Search Zepbound Clinics →Related Zepbound resources
Find Zepbound Clinics by State
Ready to start Zepbound?
Search our directory of 3,323 GLP-1 clinics. Filter by medication, insurance, and telehealth availability.
Medical Disclaimer: This guide is for informational purposes only and is not medical advice. All clinical data is sourced from FDA prescribing information and published peer-reviewed trials. Individual results vary. Always consult a qualified healthcare provider before starting, stopping, or switching any medication.